Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Quantao Zeng

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
The International Journal of Neuroscience|April 18, 2014
Detecting atheromatous plaques in the aortic arch or supra-aortic arteries for more accurate stroke subtype classificationXiaoyang Cui, Simiao Wu, Quantao Zeng, et al.
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|April 23, 2015
Etiology and Risk Factors of Posterior Circulation Infarction Compared with Anterior Circulation InfarctionQuantao Zeng, Wendan Tao, Chunyan Lei, et al.
Frontiers in Immunology|November 21, 2024
Case report: Rapid clinical improvement of anti-HMGCR immune-mediated necrotizing myopathy treated with efgartigimodQuantao Zeng, Kai Chen, Li Zeng, et al.
Current Neurovascular Research|May 28, 2016
Pathogenesis and Subtype of Intracerebral Hemorrhage (ICH) and ICH Score Determines PrognosisChunyan Lei, Bo Wu, Ming Liu, et al.
The Cochrane Database of Systematic Reviews|July 21, 2015
Buflomedil for acute ischaemic strokeSimiao Wu, Quantao Zeng, Ming Liu, et al.
Journal of Evidence-Based Medicine|May 16, 2013
Assessment of methodological quality and outcome measures of acute stroke randomized controlled trials in China in recent 15 yearsSha He, Simiao Wu, Quantao Zeng, et al.
Transplantation|April 6, 2013
Controlled-dose versus fixed-dose mycophenolate mofetil for kidney transplant recipients: a systematic review and meta-analysis of randomized controlled trialsXianding Wang, Xin Qin, Yong Wang, et al.
Therapeutic Advances in Neurological Disorders|December 30, 2024
Eculizumab in thymoma-associated myasthenia gravis: a real-world cohort studyLei Jin, Dingxian He, Quantao Zeng, et al.
Annals of Clinical and Translational Neurology|July 8, 2024
Efgartigimod for generalized myasthenia gravis: A multicenter real-world cohort study in ChinaSushan Luo, Qilong Jiang, Wenshuang Zeng, et al.
Therapeutic Advances in Neurological Disorders|February 20, 2025
Patterns and predictors of therapeutic response to efgartigimod in acetylcholine receptor-antibody generalized myasthenia gravis subtypesLei Jin, Zhangyu Zou, Qinzhou Wang, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
The International Journal of Neuroscience|April 18, 2014
Detecting atheromatous plaques in the aortic arch or supra-aortic arteries for more accurate stroke subtype classificationXiaoyang Cui, Simiao Wu, Quantao Zeng, et al.
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|April 23, 2015
Etiology and Risk Factors of Posterior Circulation Infarction Compared with Anterior Circulation InfarctionQuantao Zeng, Wendan Tao, Chunyan Lei, et al.
Frontiers in Immunology|November 21, 2024
Case report: Rapid clinical improvement of anti-HMGCR immune-mediated necrotizing myopathy treated with efgartigimodQuantao Zeng, Kai Chen, Li Zeng, et al.
Current Neurovascular Research|May 28, 2016
Pathogenesis and Subtype of Intracerebral Hemorrhage (ICH) and ICH Score Determines PrognosisChunyan Lei, Bo Wu, Ming Liu, et al.
The Cochrane Database of Systematic Reviews|July 21, 2015
Buflomedil for acute ischaemic strokeSimiao Wu, Quantao Zeng, Ming Liu, et al.
Journal of Evidence-Based Medicine|May 16, 2013
Assessment of methodological quality and outcome measures of acute stroke randomized controlled trials in China in recent 15 yearsSha He, Simiao Wu, Quantao Zeng, et al.
Transplantation|April 6, 2013
Controlled-dose versus fixed-dose mycophenolate mofetil for kidney transplant recipients: a systematic review and meta-analysis of randomized controlled trialsXianding Wang, Xin Qin, Yong Wang, et al.
Therapeutic Advances in Neurological Disorders|December 30, 2024
Eculizumab in thymoma-associated myasthenia gravis: a real-world cohort studyLei Jin, Dingxian He, Quantao Zeng, et al.
Annals of Clinical and Translational Neurology|July 8, 2024
Efgartigimod for generalized myasthenia gravis: A multicenter real-world cohort study in ChinaSushan Luo, Qilong Jiang, Wenshuang Zeng, et al.
Therapeutic Advances in Neurological Disorders|February 20, 2025
Patterns and predictors of therapeutic response to efgartigimod in acetylcholine receptor-antibody generalized myasthenia gravis subtypesLei Jin, Zhangyu Zou, Qinzhou Wang, et al.
Pageof 1